Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 1.780
-0.090 (-4.81%)
Feb 11, 2026, 2:54 PM CET
Sprint Bioscience AB Market Cap
Sprint Bioscience AB has a market cap or net worth of 197.31 million as of February 11, 2026. Its market cap has increased by 66.43% in one year.
Market Cap
197.31M
Enterprise Value
186.37M
Revenue
50.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.78
Market Cap Chart
Since November 7, 2014, Sprint Bioscience AB's market cap has increased from 62.49M to 197.31M, an increase of 215.73%. That is a compound annual growth rate of 10.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 197.31M | 27.21% |
| Dec 30, 2025 | 155.11M | 40.43% |
| Dec 30, 2024 | 110.46M | -8.82% |
| Dec 29, 2023 | 121.14M | 449.78% |
| Dec 30, 2022 | 22.03M | -88.47% |
| Dec 30, 2021 | 191.05M | 17.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Works Technologies AB | 261.49M |
| Xintela AB | 248.04M |
| Elicera Therapeutics AB | 247.53M |
| Magle Chemoswed Holding AB | 237.47M |
| AlzeCure Pharma AB | 218.34M |
| Xbrane Biopharma AB | 214.30M |
| Initiator Pharma | 205.36M |
| NextCell Pharma AB | 174.89M |